Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wan-Teck Lim

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
Clinical Lung Cancer|June 3, 2026
Development and Validation of Lung Cancer Risk Prediction Models in the Singapore Chinese PopulationYah Ru Juang, Wenjia Chen, Alvin Jing Hui Ng, et al.
Cancer Biology & Therapy|November 15, 2006
EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissuesQingyu Zhou, Yin Bun Cheung, Srinivasa Rao Jada, et al.
Cancer|July 11, 2008
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinomaSwan Swan Leong, Joseph Wee, Sandeep Rajan, et al.
Cancer Chemotherapy and Pharmacology|April 7, 2011
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patientsSin-Chi Chew, Onkar Singh, Xiangai Chen, et al.
Public Health|February 19, 2025
Interaction between polygenic risk score and reproductive factors in relation to lung cancer risk among Singaporean Chinese womenXin Yin, Jin Fang Chai, Gillianne Geet Yi Lai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysisChee-Kian Tham, Su-Pin Choo, Wan-Teck Lim, et al.
Journal of Geriatric Oncology|March 18, 2015
Do elderly patients benefit from enrollment into Phase I Trials?Wai Meng Tai, Cindy Lim, Aziah Ahmad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2009
Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomasChee-Keong Toh, Baidah Ahmad, Richie Soong, et al.
Cancer Letters|December 23, 2016
Metronomic chemotherapy: A relook at its basis and rationaleTanujaa Rajasekaran, Quan-Sing Ng, Daniel Shao-Weng Tan, et al.
Plos One|May 3, 2016
Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different SchedulesNatalia Sutiman, Zhenxian Zhang, Eng Huat Tan, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
Clinical Lung Cancer|June 3, 2026
Development and Validation of Lung Cancer Risk Prediction Models in the Singapore Chinese PopulationYah Ru Juang, Wenjia Chen, Alvin Jing Hui Ng, et al.
Cancer Biology & Therapy|November 15, 2006
EGFR Intron 1 polymorphism in Asian Populations and its correlation with EGFR gene expression and amplification in breast tumor tissuesQingyu Zhou, Yin Bun Cheung, Srinivasa Rao Jada, et al.
Cancer|July 11, 2008
Triplet combination of gemcitabine, paclitaxel, and carboplatin followed by maintenance 5-fluorouracil and folinic acid in patients with metastatic nasopharyngeal carcinomaSwan Swan Leong, Joseph Wee, Sandeep Rajan, et al.
Cancer Chemotherapy and Pharmacology|April 7, 2011
The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patientsSin-Chi Chew, Onkar Singh, Xiangai Chen, et al.
Public Health|February 19, 2025
Interaction between polygenic risk score and reproductive factors in relation to lung cancer risk among Singaporean Chinese womenXin Yin, Jin Fang Chai, Gillianne Geet Yi Lai, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 24, 2009
Gefitinib in combination with gemcitabine and carboplatin in never smokers with non-small cell lung carcinoma: a retrospective analysisChee-Kian Tham, Su-Pin Choo, Wan-Teck Lim, et al.
Journal of Geriatric Oncology|March 18, 2015
Do elderly patients benefit from enrollment into Phase I Trials?Wai Meng Tai, Cindy Lim, Aziah Ahmad, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|October 31, 2009
Correlation between epidermal growth factor receptor mutations and expression of female hormone receptors in East-Asian lung adenocarcinomasChee-Keong Toh, Baidah Ahmad, Richie Soong, et al.
Cancer Letters|December 23, 2016
Metronomic chemotherapy: A relook at its basis and rationaleTanujaa Rajasekaran, Quan-Sing Ng, Daniel Shao-Weng Tan, et al.
Plos One|May 3, 2016
Phase I Study of Oral Vinorelbine in Combination with Erlotinib in Advanced Non-Small Cell Lung Cancer (NSCLC) Using Two Different SchedulesNatalia Sutiman, Zhenxian Zhang, Eng Huat Tan, et al.
Pageof 16